Piperidine derivatives as serotonine reuptake inhibitors
申请人:Eli Lilly and Company
公开号:US06664274B1
公开(公告)日:2003-12-16
The present invention provides compounds of formula I
and a method of inhibiting the reuptake of serotonin, antagonizing the 5-HT1A receptor and antagonizing the 5-HT2A receptor which comprises administering to a subject in need of such treatment an effective amount of a compound of formula I.